Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics US
December 13 - 16, 2026
Marriott Marquis San Diego
Book Now
Menu
Book Now

Katelyn Willis
Group Leader - Cell Biology at InhibRx
Speaker

Profile

Dr. Katelyn Willis is the Director of Biotherapeutics at Inhibrx Biosciences, Inc. Prior to joining Inhibrx in 2014, Dr. Willis was a postdoctoral scholar at the Moores Cancer Center at UCSD, where she completed the Cancer Therapeutics Training (CT2) and Clinical Research Enhancement through Supplemental Training (CREST) programs. Dr. Willis received her B.A. in Biology from Amherst College and her Ph.D. in Molecular and Medical Pharmacology from UCLA.

Agenda Sessions

  • Ozekibart: A Tetravalent Antibody Precisely Engineered for Optimal DR5 Agonism and Safety

    , 3:15pm
    View Session

At this event

Prev
Next
Andreas Evers
Scientific Director in Antibody Discovery & Protein Engineering, Global Research & Development, Discovery Technologies
Merck Healthcare

See Katelyn at Antibody Engineering & Therapeutics US

Book Now